Envestnet Asset Management’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-5,745
Closed -$236K – 3531
2020
Q4
$236K Sell
5,745
-9,373
-62% -$366K ﹤0.01% 3052
2020
Q3
$564K Sell
15,118
-2,917
-16% -$108K ﹤0.01% 2386
2020
Q2
$621K Sell
18,035
-6,101
-25% -$190K ﹤0.01% 2275
2020
Q1
$676K Sell
24,136
-154
-0.6% -$5.13K ﹤0.01% 2044
2019
Q4
$844K Buy
24,290
+8,069
+50% +$273K ﹤0.01% 2135
2019
Q3
$523K Buy
16,221
+941
+6% +$32.2K ﹤0.01% 2341
2019
Q2
$524K Buy
15,280
+6,466
+73% +$218K ﹤0.01% 2376
2019
Q1
$295K Buy
8,814
+896
+11% +$28.2K ﹤0.01% 2605
2018
Q4
$219K Buy
+7,918
New +$246K ﹤0.01% 2636

Other funds holding FFTY

Envestnet Asset Management's FFTY Position: Q1 2021 in Review

Envestnet Asset Management sold out of CapForce IBD 50 ETF (FFTY) in Q1 2021, closing a stake of 5,745 shares — an estimated $236K sold.

Envestnet Asset Management first reported a position in FFTY in Q4 2018 and held it in 9 quarters. The position peaked at $844K in Q4 2019. 68 funds tracked by Wall St. Rank hold FFTY as of Q1 2021.

  • Envestnet Asset Management reported no remaining CapForce IBD 50 ETF position as of Q1 2021 after selling out during the quarter.
  • Envestnet Asset Management sold 5,745 CapForce IBD 50 ETF shares in Q1 2021, an estimated $236K.
  • Envestnet Asset Management first reported a position in CapForce IBD 50 ETF in Q4 2018 and held it in 9 quarters.
  • Envestnet Asset Management's CapForce IBD 50 ETF position peaked at $844K in Q4 2019.
  • 68 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2021.

Based on Envestnet Asset Management's 13F filing for Q1 2021, filed 4 May 2021.